Tumour budding with and without admixed inflammation: two different sides of the same coin?

被引：16

作者：

Max, Nicole ^{[1
]}

Harbaum, Lars ^{[2
]}

Pollheimer, Marion J. ^{[1
]}

Lindtner, Richard A. ^{[3
]}

Kornprat, Peter ^{[4
]}

Langner, Cord ^{[1
]}

机构：

[1] Med Univ, Inst Pathol, Auenbruggerpl 25, A-8036 Graz, Austria

[2] Univ Med Ctr Hamburg Eppendorf, BMT Sect Pneumol, Dept Oncol, Haematol,BMT Sect Pneumol, Martinistr 52, D-20246 Hamburg, Germany

[3] Med Univ Innsbruck, Dept Surg, Innrain 52, A-6020 Innsbruck, Austria

[4] Med Univ, Dept Surg, Auenbruggerpl 29, A-8036 Graz, Austria

来源：

BRITISH JOURNAL OF CANCER | 2016年 / 114卷 / 04期

关键词：

colorectal cancer; tumour budding; inflammation; prognosis; survival; multivariate logistic regression; epithelial-mesenchymal transition; II COLORECTAL-CANCER; CARCINOMA; MARKER; INDEX;

D O I：

10.1038/bjc.2015.454

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Tumour budding is an adverse prognostic indicator in colorectal cancer (CRC). Marked overall peritumoural inflammation has been associated with favourable outcome and may lead to the presence of isolated cancer cells due to destruction of invading cancer cell islets. Methods: We assessed the prognostic significance of tumour budding and peritumoural inflammation in a cohort of 381 patients with CRC applying univariate and multivariate analyses. Results: Patients with high-grade budding and marked inflammation had a significantly better outcome compared with patients with high-grade budding and only mild inflammation. Outcome in these cases, however, was still worse compared with cases with low-grade budding, in which the extent of peritumoural inflammation had no further prognostic effect. Conclusions: Tumour budding proved to be a powerful prognostic variable in patients with CRC. Scattering of invading cancer cell islets by marked overall peritumoural inflammation seems to have a minor role.

引用

页码：368 / 371

页数：4

共 23 条

[1] Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer [J].

Betge, Johannes ;

Kornprat, Peter ;

Pollheimer, Marion J. ;

Lindtner, Richard A. ;

Schlemmer, Andrea ;

Rehak, Peter ;

Vieth, Michael ;

Langner, Cord .

ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (12) :3706-3712

[2] Tumor budding as a prognostic marker in stage-III rectal carcinoma [J].

Choi, Hong-Jo ;

Park, Ki-Jae ;

Shin, Jong-Sok ;

Roh, Mee-Sook ;

Kwon, Hyuk-Chan ;

Lee, Hyung-Sik .

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (08) :863-868

[3] The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome [J].

Dawson, Heather ;

Koelzer, Viktor H. ;

Karamitopoulou, Eva ;

Economou, Mary ;

Hammer, Caroline ;

Muller, Dominique-Elisabeth ;

Lugli, Alessandro ;

Zlobec, Inti .

HISTOPATHOLOGY, 2014, 64 (04) :577-584

[4] Peritumoral eosinophils predict recurrence in colorectal cancer [J].

Harbaum, Lars ;

Pollheimer, Marion J. ;

Kornprat, Peter ;

Lindtner, Richard A. ;

Bokemeyer, Carsten ;

Langner, Cord .

MODERN PATHOLOGY, 2015, 28 (03) :403-413

[5] Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer [J].

Horcic, Milo ;

Koelzer, Viktor H. ;

Karamitopoulou, Eva ;

Terracciano, Luigi ;

Puppa, Giacomo ;

Zlobec, Inti ;

Lugli, Alessandro .

HUMAN PATHOLOGY, 2013, 44 (05) :697-705

[6] Tumour budding at invasive margins and outcome in colorectal cancer [J].

Kanazawa, H. ;

Mitomi, H. ;

Nishiyama, Y. ;

Kishimoto, I. ;

Fukui, N. ;

Nakamura, T. ;

Watanabe, M. .

COLORECTAL DISEASE, 2008, 10 (01) :41-47

[7] Proposal for a 10-high-power-fields scoring rnethod for the assessment of tumor budding in colorectal cancer [J].

Karamitopoulou, Eva ;

Zlobec, Inti ;

Koelzer, Viktor ;

Kondi-Pafiti, Agathi ;

Patsouris, Efstratios S. ;

Gennatas, Konstantin ;

Lugli, Alessandro .

MODERN PATHOLOGY, 2013, 26 (02) :295-301

[8] Inflammation and prognosis in colorectal cancer [J].

Klintrup, K ;

Mäkinen, JM ;

Kauppila, S ;

Väre, PO ;

Melkko, J ;

Tuominen, H ;

Tuppurainen, K ;

Mäkelä, J ;

Karttunen, TJ ;

Mäkinen, MJ .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (17) :2645-2654

[9] Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome [J].

Koelzer, Viktor H. ;

Dawson, Heather ;

Andersson, Emilia ;

Karamitopoulou, Eva ;

Masucci, Giuseppe V. ;

Lugli, Alessandro ;

Zlobec, Inti .

TRANSLATIONAL RESEARCH, 2015, 166 (02) :207-217

[10] Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study [J].

Koelzer, Viktor H. ;

Zlobec, Inti ;

Berger, Martin D. ;

Cathomas, Gieri ;

Dawson, Heather ;

Dirschmid, Klaus ;

Hadrich, Marion ;

Inderbitzin, Daniel ;

Offner, Felix ;

Puppa, Giacomo ;

Seelentag, Walter ;

Schnueriger, Beat ;

Tornillo, Luigi ;

Lugli, Alessandro .

VIRCHOWS ARCHIV, 2015, 466 (05) :485-493

← 1 2 3 →